发明名称 |
Combinations of a muscarinic receptor antagonist and a beta-2 adrenoreceptor agonist |
摘要 |
Combinations of a muscarinic receptor Antagonist Which is 4-[hydroxy(diphenyl)methyl]-1-{ 2[(phenylmethyl)oxy]ethyl} -1-azoniabicyclo[2.2.2]octane bromide (Umeclidinium) and a Beta-2 Adrenoreceptor Agonist (LABA) Which is 4-{ (1R)-2-[(6-{ 2-[(2,6-dichlorobenzyl)oxy]ethoxy} hexyl)amino]-1-hydroxyethyl} -2-(hydroxymethyl)phenol triphenylacetate(vilanterol), for treating COPD. The compositions are suitable for for inhaled administration via the nose or mouth, and methods of using them are provided. |
申请公布号 |
NZ600026(A) |
申请公布日期 |
2014.06.27 |
申请号 |
NZ20100600026 |
申请日期 |
2010.11.29 |
申请人 |
GLAXO GROUP LIMITED |
发明人 |
BAKER DARRELL;BRUCE MARK;CRATER GLENN;NOGA BRIAN;THOMAS MARIAN;WIRE PATRICK |
分类号 |
A61K31/138;A61K31/439;A61K45/06;A61P11/06;A61P11/08 |
主分类号 |
A61K31/138 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|